SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-17-028400
Filing Date
2017-05-01
Accepted
2017-05-01 16:07:24
Documents
6
Period of Report
2017-06-22
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A a17-2135_1def14a.htm DEF 14A 490212
2 GRAPHIC g21351boi001.jpg GRAPHIC 113041
3 GRAPHIC g21351boi002.jpg GRAPHIC 99027
4 GRAPHIC g21351bci001.gif GRAPHIC 4918
5 GRAPHIC g21351bci002.gif GRAPHIC 2158
6 GRAPHIC g21351bci003.gif GRAPHIC 2611
  Complete submission text file 0001104659-17-028400.txt   797199
Mailing Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address 281 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-653-3880
Loxo Oncology, Inc. (Filer) CIK: 0001581720 (see all company filings)

IRS No.: 462996673 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36562 | Film No.: 17800761
SIC: 2834 Pharmaceutical Preparations